Skip to content

LG H&H Co., Ltd. A clinical study of “PHYSIOGEL RED SOOTHING ROSATECA REDNESS REDUCING SERUM” on suitability for Rosacea-Prone skin

LG H&H Co., Ltd. Clinical study to evaluate the suitability of the serum(tentatively named) for use on rosacea-prone skin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011944
Enrollment
31
Registered
2026-05-08
Start date
2025-10-16
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(cosmetic) : The participants dispensed an appropriate amount of the test product using a dropper and evenly applied it to the entire face twice daily (morning and evening) at the serum/essence

Sponsors

Global Medical Research Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male and female participants aged 20 to 59 years who have been diagnosed with Rosacea (including those with a prior history of diagnosis) or are suspected of having rosacea-prone skin. 2) Individuals who are fully aware of the purpose and contents of the examination and voluntarily signed written consent 3) Individuals who can be followed up during the study period 4) Healthy individuals without acute or chronic disease including skin diseases

Exclusion criteria

Exclusion criteria: 1) Pregnant or breast-feeding women and women of childbearing age who disagree with the protocol for contraception 2) Individualswho were determined by a dermatologist to have active skin diseases, other than rosacea, that require medical treatment. 3) Individuals who have infectious skin diseases 4) Individuals with allergies or hypersensitivity 5) Individuals who have irritation with cosmetics, medicine, or sunlight exposure 6) Individuals who have received systemic steroids or phototherapy a month before participation 7) Individuals who have received skincare and/or skin procedures (scaling / BOTOX / filler / laser / tattoo) 3 months before participation 8) Individuals who used the same or similar cosmetics or medicine at the test site within 3 months before the start of the study 9) Individuals with mental illness or mental retardation 10) In addition to the above, if the responsible researcher or the principal investigator determines that it is difficult to perform the clinical study

Design outcomes

Primary

MeasureTime frame
Dermatologist Visual Assessment and Inquiry_Acne-inducing potential(Open comedones / Closed comedones / Papules / Pustules / Nodules);Dermatologist Visual Assessment and Inquiry_Evaluation of Skin Condition(Objective evaluation_Erythema / Edema / Desquamation / Papule / other);Dermatologist Visual Assessment and Inquiry_Evaluation of Skin Condition(Subjective evaluation_Itching / Prickling / Burning / other);Skin Barrier;Skin Redness

Secondary

MeasureTime frame
Survey(Redness care, Sensitive skin soothing, QOL, Improvement of damaged skin barrier, other)

Countries

Korea, Republic of

Contacts

Public ContactSang A Woo

Global Medical Research Center

woobea@gmrc.co.kr+82-70-8801-7352

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: May 16, 2026